miR‐451a suppresses the proliferation and migration of high‐grade serous ovarian cancer by targeting RAB5A through the Ras/Raf/MEK/ERK pathway
The Journal of Gene Medicine · 2024
DOI: 10.1002/jgm.3649 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Gene Medicine, 2024. Verfasst von Shujie Liu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Qilu Hospital of Shandong University, Jinan, Shandong, China. Hauptthemen laut MEDLINE: MicroRNAs, Ovarian Neoplasms, rab5 GTP-Binding Proteins. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 25 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Background
Ovarian cancer is one of the most common cancers in women. Profiles changes of microRNAs (miRNAs) are closely linked to malignant tumors. In the present study, we investigated expression of miR‐451a in high‐grade serous ovarian cancer (HGSOC). We also investigated the potential pathological roles and the likely mechanism of miR‐451a in the development of HGSOC using animal models and cell lines.
Methods
Using bioinformatics techniques and a real‐time PCR, we analyzed differently expressed miRNAs in HGSOC compared to normal tissue. MTT (i.e. 3‐[4, 5‐dimethyl thiazol‐2‐yl]‐2,5‐diphenyl tetrazolium bromide), EDU (i.e. 5‐ethynyl‐2′‐deoxyuridine) and transwell assays were performed to investigate the effect of miR‐451a on the proliferation and migration of HGSOC SKOV‐3 cells. A dual luciferase reporter assay was performed to verify the targeting relationship of miR‐451 and RAB5A (one of the Rab GTPase proteins that regulates endocytosis and vesicle transport). Also, we analyzed levels of the RAB5A mRNA and protein by real‐time PCR, western blotting and immunohistochemistry assays in HGSOC cells and tissues. Finally, we performed in vivo experiments using HGSOC mice. Results miR‐451a was substantially upregulated in HGSOC and associated with favorable clinical characteristics. miR‐451a knockdown significantly increased growth and metastasis of HGSOC cell line SKOV‐3 through Ras/Raf/mitogen‐activated protein kinase kinase (MEK)/extracellular signal‐regulated kinase (ERK) signaling. In addition, RAB5A, an early endosome marker, was shown to be a direct target of miR‐451a. Moreover, RAB5A is correlated with unfavorable clinical features and shows independent prognostic significance in HGSOC.
Conclusions
We found that the miR‐451a/RAB5A axis is associated with tumorigenesis and progression through the Ras/Raf/MEK/ERK pathway, providing prognostic indicators and therapeutic targets for patients with HGSOC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, Qilu Hospital of Shandong University, Jinan, Shandong, China.
- Department of Gynecology, Shandong Provincial Hospital affiliated to Shandong First Medical University, Jinan, China.
- Department of Ultrasound Medcine, Shandong Provincial Hospital affiliated to Shandong First Medical University, Jinan, China.
- Department of Pathology, The Afliated Taian City Central Hospital of Qingdao University, Tai'an, China.
- Department of Gastroenterology, The Afliated Taian City Central Hospital of Qingdao University, Tai'an, China.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Liu, S., Wang, K., Zhao, Z., Pang, Y., Liu, F., Wang, P., Wang, Z., & Yang, X. (2024). miR‐451a suppresses the proliferation and migration of high‐grade serous ovarian cancer by targeting RAB5A through the Ras/Raf/MEK/ERK pathway. The Journal of Gene Medicine. https://doi.org/10.1002/jgm.3649
Vancouver
Liu S, Wang K, Zhao Z, Pang Y, Liu F, Wang P, et al. miR‐451a suppresses the proliferation and migration of high‐grade serous ovarian cancer by targeting RAB5A through the Ras/Raf/MEK/ERK pathway. The Journal of Gene Medicine. 2024. doi:10.1002/jgm.3649
BibTeX
@article{Liu2024,
author = {Liu, Shujie and Wang, Kun and Zhao, Zhendan and Pang, Yu and Liu, Fang and Wang, Pengling and Wang, Zhiling and Yang, Xingsheng},
title = {miR‐451a suppresses the proliferation and migration of high‐grade serous ovarian cancer by targeting RAB5A through the Ras/Raf/MEK/ERK pathway},
journal = {The Journal of Gene Medicine},
year = {2024},
doi = {10.1002/jgm.3649}
}
EUVIMED